Glucose production in glycogen storage disease I is not associated with increased cycling through hepatic glycogen.
Children with glycogen storage disease type I (GSD I) lack the ability to convert glucose 6-phosphate to glucose and yet are able to produce glucose endogenously. To test the hypothesis that the source of this glucose is increased cycling of glucose moieties through hepatic glycogen, six children with GSD I were studied on two occasions during which they received enteral glucose for 6 h at 35 or 50 mumol.kg-1.min-1 along with [6,6-2H2]glucose to measure plasma glucose flux and [1-13C]galactose to label intrahepatic uridyl diphosphate (UDP)-glucose. After 3 h, acetaminophen was given to estimate UDP-glucose flux (reflecting the rate of glycogen synthesis). Mean steady-state plasma glucose concentrations (4.8 +/- 0.2 vs. 5.8 +/- 0.1 mM) and total flux (34.8 +/- 1.7 vs. 47.5 +/- 2.0 mumol.kg-1.min-1) were increased (P < 0.05 or better) on the high-infusion day. Endogenous glucose production was detectable only on the low-infusion day (2.0 +/- 0.5 mumol.kg-1.min-1). UDP-glucose flux was increased (P < 0.05) on the high-infusion day (25.8 +/- 1.6 vs. 34.7 +/- 4.1), ruling out cycling of glucose moieties through glycogen with release of glucose by debrancher enzyme as the source of glucose production.
D001786:Blood Glucose / Q000032:analysis; D002247:Carbon Isotopes; D002648:Child; D003903:Deuterium; D004750:Enteral Nutrition; D005947:Glucose / Q000008:administration & dosage / Q000096:biosynthesis* / Q000494:pharmacology; D006003:Glycogen / Q000378:metabolism; D005953:Glycogen Storage Disease Type I / Q000378:metabolism*; D006801:Humans; D008099:Liver / Q000378:metabolism*; D014532:Uridine Diphosphate Glucose / Q000378:metabolism
D001786:Blood Glucose; D002247:Carbon Isotopes; D006003:Glycogen; D003903:Deuterium; D005947:Glucose; D014532:Uridine Diphosphate Glucose